4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-004605
Chief Executive Officer sold 30,601 shares at $0.58 ($17,773)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2025-01-17 | Sale | −30,601 | $0.58 | $17,773 | 44,327 | D: show line 1 in the form |
| Open-market sales · 30,601 sh · avg $0.58 · $17,773 | |||||||
Loading xslF345X05/tm253716-1_4seq1.xml…